Saturday 17 October 2026 Export NVCT’s income statement to Excel — free account

Nuvectis Pharma, Inc.

In the quarter to June 2026, EPS was flat and free cash flow fell 34.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

18.48 0.45 −2.38%

Follow NVCT

Alert me

Market cap: $618.0M
P/E: 0.0×
Fwd P/E: —
Dividend yield: —
F-score: n/a
Altman Z: n/a
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(233.30%)	(168.24%)	(205.30%)	(158.88%)	+8 more TTM periods Free account
ROA Full definition →	(122.61%)	(106.54%)	(114.76%)	(105.13%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(333.35%)	(208.08%)	(156.80%)	(115.81%)
Free Cash Flow per Share Full definition →	(0.83)	(0.78)	(0.73)	(0.64)
Free Cash Flow Full definition →	(19.51)	(18.35)	(16.01)	(14.50)
Other line items
Cash ROIC Full definition →	(62.45%)	(46.62%)	(31.99%)	(24.39%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.64	0.62	0.55	0.52
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.83)	(0.78)	(0.73)	(0.64)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly